A detailed history of B&L Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, B&L Asset Management LLC holds 7,090 shares of ABT stock, worth $947,011. This represents 0.62% of its overall portfolio holdings.

Number of Shares
7,090
Previous 7,527 5.81%
Holding current value
$947,011
Previous $851 Million 10.47%
% of portfolio
0.62%
Previous 0.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$111.1 - $140.22 $48,550 - $61,276
-437 Reduced 5.81%
7,090 $940 Million
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $753,226 - $889,164
7,527 New
7,527 $858 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $234B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track B&L Asset Management LLC Portfolio

Follow B&L Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B&L Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on B&L Asset Management LLC with notifications on news.